Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients With IgAN

NCT07020923 is registered in ClinicalTrials.gov with Vera Therapeutics, Inc. as lead sponsor.

NCT NCT07020923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating Monthly (Every 4 Weeks) Dosing of Atacicept in Patients With IgAN
Lead sponsor
Vera Therapeutics, Inc.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 29, 2025
Completion date
September 30, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

berger disease, iga nephropathy (igan)